T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement
The Company continues to prioritize maintaining its Nasdaq listing and considers it to be in the best interest of both the Company and its stockholders.
- The Company continues to prioritize maintaining its Nasdaq listing and considers it to be in the best interest of both the Company and its stockholders.
- Listing on the Nasdaq Stock Market maintains liquidity for stockholders, helps attract and retain key employees, broadens its access to capital, and better positions the Company for potential mergers and acquisitions.
- The Rule requires that the Company maintain a closing Market Value of at least $35.0 million for a minimum of ten consecutive business days.
- There can be no assurance, however, that the Company will be able to timely comply with the terms of the Nasdaq Hearings Panel’s decision.